This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pfaller, M. A.
Right arrow Articles by Diekema, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pfaller, M. A.
Right arrow Articles by Diekema, D. J.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, January 2007, p. 133-163, Vol. 20, No. 1
0893-8512/07/$08.00+0     doi:10.1128/CMR.00029-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

M. A. Pfaller1,3* and D. J. Diekema1,2

Departments of Pathology,1 Medicine, College of Medicine,2 Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa 522423

Invasive candidiasis (IC) is a leading cause of mycosis-associated mortality in the United States. We examined data from the National Center for Health Statistics and reviewed recent literature in order to update the epidemiology of IC. IC-associated mortality has remained stable, at approximately 0.4 deaths per 100,000 population, since 1997, while mortality associated with invasive aspergillosis has continued to decline. Candida albicans remains the predominant cause of IC, accounting for over half of all cases, but Candida glabrata has emerged as the second most common cause of IC in the United States, and several less common Candida species may be emerging, some of which can exhibit resistance to triazoles and/or amphotericin B. Crude and attributable rates of mortality due to IC remain unacceptably high and unchanged for the past 2 decades. Nonpharmacologic preventive strategies should be emphasized, including hand hygiene; appropriate use, placement, and care of central venous catheters; and prudent use of antimicrobial therapy. Given that delays in appropriate antifungal therapy are associated with increased mortality, improved use of early empirical, preemptive, and prophylactic therapies should also help reduce IC-associated mortality. Several studies have now identified important variables that can be used to predict risk of IC and to help guide preventive strategies such as antifungal prophylaxis and early empirical therapy. However, improved non-culture-based diagnostics are needed to expand the potential for preemptive (or early directed) therapy. Further research to improve diagnostic, preventive, and therapeutic strategies is necessary to reduce the considerable morbidity and mortality associated with IC.

* Corresponding author. Mailing address: Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242. Phone: (319) 356-8615. Fax: (319) 356-4916. E-mail: michael-pfaller{at}uiowa.edu.

Clinical Microbiology Reviews, January 2007, p. 133-163, Vol. 20, No. 1
0893-8512/07/$08.00+0     doi:10.1128/CMR.00029-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Cuesta, I., Bielza, C., Larranaga, P., Cuenca-Estrella, M., Laguna, F., Rodriguez-Pardo, D., Almirante, B., Pahissa, A., Rodriguez-Tudela, J. L. (2009). Data Mining Validation of Fluconazole Breakpoints Established by the European Committee on Antimicrobial Susceptibility Testing. Antimicrob. Agents Chemother. 53: 2949-2954 [Abstract] [Full Text]  
  • Asadzadeh, M., Ahmad, S., Al-Sweih, N., Khan, Z. U. (2009). Rapid molecular differentiation and genotypic heterogeneity among Candida parapsilosis and Candida orthopsilosis strains isolated from clinical specimens in Kuwait. J Med Microbiol 58: 745-752 [Abstract] [Full Text]  
  • Verweij, P. E., Maertens, J. (2009). Moulds: diagnosis and treatment. J Antimicrob Chemother 63: i31-i35 [Abstract] [Full Text]  
  • Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., Monk, B. C. (2009). Efflux-Mediated Antifungal Drug Resistance. Clin. Microbiol. Rev. 22: 291-321 [Abstract] [Full Text]  
  • Lockhart, S. R., Messer, S. A., Gherna, M., Bishop, J. A., Merz, W. G., Pfaller, M. A., Diekema, D. J. (2009). Identification of Candida nivariensis and Candida bracarensis in a Large Global Collection of Candida glabrata Isolates: Comparison to the Literature. J. Clin. Microbiol. 47: 1216-1217 [Abstract] [Full Text]  
  • Rossignol, T., Ding, C., Guida, A., d'Enfert, C., Higgins, D. G., Butler, G. (2009). Correlation between Biofilm Formation and the Hypoxic Response in Candida parapsilosis. Eukaryot Cell 8: 550-559 [Abstract] [Full Text]  
  • Arendrup, M. C., Garcia-Effron, G., Buzina, W., Mortensen, K. L., Reiter, N., Lundin, C., Jensen, H. E., Lass-Florl, C., Perlin, D. S., Bruun, B. (2009). Breakthrough Aspergillus fumigatus and Candida albicans Double Infection during Caspofungin Treatment: Laboratory Characteristics and Implication for Susceptibility Testing. Antimicrob. Agents Chemother. 53: 1185-1193 [Abstract] [Full Text]  
  • Balish, E. (2009). A URA3 null mutant of Candida albicans (CAI-4) causes oro-oesophageal and gastric candidiasis and is lethal for gnotobiotic, transgenic mice (Tg{epsilon}26) that are deficient in both natural killer and T cells. J Med Microbiol 58: 290-295 [Abstract] [Full Text]  
  • Cowen, L. E., Singh, S. D., Kohler, J. R., Collins, C., Zaas, A. K., Schell, W. A., Aziz, H., Mylonakis, E., Perfect, J. R., Whitesell, L., Lindquist, S. (2009). Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc. Natl. Acad. Sci. USA 106: 2818-2823 [Abstract] [Full Text]  
  • Lee, I., Fishman, N. O., Zaoutis, T. E., Morales, K. H., Weiner, M. G., Synnestvedt, M., Nachamkin, I., Lautenbach, E. (2009). Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream Infections. Arch Intern Med 169: 379-383 [Abstract] [Full Text]  
  • ten Cate, J.M., Klis, F.M., Pereira-Cenci, T., Crielaard, W., de Groot, P.W.J. (2009). Molecular and Cellular Mechanisms That Lead to Candida Biofilm Formation. JDR 88: 105-115 [Abstract] [Full Text]  
  • Tay, S. T., Na, S. L., Chong, J. (2009). Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections. J Med Microbiol 58: 185-191 [Abstract] [Full Text]  
  • Romeo, O., Criseo, G. (2009). Molecular Epidemiology of Candida albicans and Its Closely Related Yeasts Candida dubliniensis and Candida africana. J. Clin. Microbiol. 47: 212-214 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Bijie, H., Dzierzanowska, D., Klimko, N. N., Letscher-Bru, V., Lisalova, M., Muehlethaler, K., Rennison, C., Zaidi, M., the Global Antifungal Surveillance Group, (2009). Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing. J. Clin. Microbiol. 47: 117-123 [Abstract] [Full Text]  
  • Tumbarello, M., Sanguinetti, M., Trecarichi, E. M., La Sorda, M., Rossi, M., de Carolis, E., de Gaetano Donati, K., Fadda, G., Cauda, R., Posteraro, B. (2008). Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome. J Antimicrob Chemother 62: 1379-1385 [Abstract] [Full Text]  
  • Sendid, B., Dotan, N., Nseir, S., Savaux, C., Vandewalle, P., Standaert, A., Zerimech, F., Guery, B. P., Dukler, A., Colombel, J. F., Poulain, D. (2008). Antibodies against Glucan, Chitin, and Saccharomyces cerevisiae Mannan as New Biomarkers of Candida albicans Infection That Complement Tests Based on C. albicans Mannan. CVI 15: 1868-1877 [Abstract] [Full Text]  
  • Rosas-Hernandez, L. L., Juarez-Reyes, A., Arroyo-Helguera, O. E., De Las Penas, A., Pan, S.-J., Cormack, B. P., Castano, I. (2008). yKu70/yKu80 and Rif1 Regulate Silencing Differentially at Telomeres in Candida glabrata. Eukaryot Cell 7: 2168-2178 [Abstract] [Full Text]  
  • Brzankalski, G. E., Najvar, L. K., Wiederhold, N. P., Bocanegra, R., Fothergill, A. W., Rinaldi, M. G., Pattterson, T. F., Graybill, J. R. (2008). Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility. J Antimicrob Chemother 62: 1094-1100 [Abstract] [Full Text]  
  • Andres, M. T., Viejo-Diaz, M., Fierro, J. F. (2008). Human Lactoferrin Induces Apoptosis-Like Cell Death in Candida albicans: Critical Role of K+-Channel-Mediated K+ Efflux. Antimicrob. Agents Chemother. 52: 4081-4088 [Abstract] [Full Text]  
  • Chauhan, N., Calderone, R. (2008). Two-Component Signal Transduction Proteins as Potential Drug Targets in Medically Important Fungi. Infect. Immun. 76: 4795-4803 [Full Text]  
  • Pfaller, M. A., Boyken, L. B., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S., Diekema, D. J. (2008). Validation of 24-Hour Fluconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Results from a Global Candida Antifungal Surveillance Program. J. Clin. Microbiol. 46: 3585-3590 [Abstract] [Full Text]  
  • Wakiec, R., Gabriel, I., Prasad, R., Becker, J. M., Payne, J. W., Milewski, S. (2008). Enhanced Susceptibility to Antifungal Oligopeptides in Yeast Strains Overexpressing ABC Multidrug Efflux Pumps. Antimicrob. Agents Chemother. 52: 4057-4063 [Abstract] [Full Text]  
  • de Groot, P. W. J., Kraneveld, E. A., Yin, Q. Y., Dekker, H. L., Gross, U., Crielaard, W., de Koster, C. G., Bader, O., Klis, F. M., Weig, M. (2008). The Cell Wall of the Human Pathogen Candida glabrata: Differential Incorporation of Novel Adhesin-Like Wall Proteins. Eukaryot Cell 7: 1951-1964 [Abstract] [Full Text]  
  • Trofa, D., Gacser, A., Nosanchuk, J. D. (2008). Candida parapsilosis, an Emerging Fungal Pathogen. Clin. Microbiol. Rev. 21: 606-625 [Abstract] [Full Text]  
  • Andes, D. R., Diekema, D. J., Pfaller, M. A., Marchillo, K., Bohrmueller, J. (2008). In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model. Antimicrob. Agents Chemother. 52: 3497-3503 [Abstract] [Full Text]  
  • Desnos-Ollivier, M., Ragon, M., Robert, V., Raoux, D., Gantier, J.-C., Dromer, F. (2008). Debaryomyces hansenii (Candida famata), a Rare Human Fungal Pathogen Often Misidentified as Pichia guilliermondii (Candida guilliermondii). J. Clin. Microbiol. 46: 3237-3242 [Abstract] [Full Text]  
  • Marcil, A., Gadoury, C., Ash, J., Zhang, J., Nantel, A., Whiteway, M. (2008). Analysis of PRA1 and Its Relationship to Candida albicans- Macrophage Interactions. Infect. Immun. 76: 4345-4358 [Abstract] [Full Text]  
  • Wrobel, L., Whittington, J. K., Pujol, C., Oh, S.-H., Ruiz, M. O., Pfaller, M. A., Diekema, D. J., Soll, D. R., Hoyer, L. L. (2008). Molecular Phylogenetic Analysis of a Geographically and Temporally Matched Set of Candida albicans Isolates from Humans and Nonmigratory Wildlife in Central Illinois. Eukaryot Cell 7: 1475-1486 [Abstract] [Full Text]  
  • Gafter-Gvili, A., Vidal, L., Goldberg, E., Leibovici, L., Paul, M. (2008). Treatment of Invasive Candidal Infections: Systematic Review and Meta-analysis. Mayo Clin Proc. 83: 1011-1021 [Abstract] [Full Text]  
  • Ruan, S.-Y., Chu, C.-C., Hsueh, P.-R. (2008). In Vitro Susceptibilities of Invasive Isolates of Candida Species: Rapid Increase in Rates of Fluconazole Susceptible-Dose Dependent Candida glabrata Isolates. Antimicrob. Agents Chemother. 52: 2919-2922 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J., Ostrosky-Zeichner, L., Rex, J. H., Alexander, B. D., Andes, D., Brown, S. D., Chaturvedi, V., Ghannoum, M. A., Knapp, C. C., Sheehan, D. J., Walsh, T. J. (2008). Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints. J. Clin. Microbiol. 46: 2620-2629 [Abstract] [Full Text]  
  • Monk, B. C., Goffeau, A. (2008). Outwitting Multidrug Resistance to Antifungals. Science 321: 367-369 [Abstract] [Full Text]  
  • Garcia-Effron, G., Katiyar, S. K., Park, S., Edlind, T. D., Perlin, D. S. (2008). A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility. Antimicrob. Agents Chemother. 52: 2305-2312 [Abstract] [Full Text]  
  • Spreghini, E., Maida, C. M., Tomassetti, S., Orlando, F., Giannini, D., Milici, M. E., Scalise, G., Barchiesi, F. (2008). Posaconazole against Candida glabrata Isolates with Various Susceptibilities to Fluconazole. Antimicrob. Agents Chemother. 52: 1929-1933 [Abstract] [Full Text]  
  • Wells, C. A., Salvage-Jones, J. A., Li, X., Hitchens, K., Butcher, S., Murray, R. Z., Beckhouse, A. G., Lo, Y.-L.-S., Manzanero, S., Cobbold, C., Schroder, K., Ma, B., Orr, S., Stewart, L., Lebus, D., Sobieszczuk, P., Hume, D. A., Stow, J., Blanchard, H., Ashman, R. B. (2008). The Macrophage-Inducible C-Type Lectin, Mincle, Is an Essential Component of the Innate Immune Response to Candida albicans. J. Immunol. 180: 7404-7413 [Abstract] [Full Text]  
  • Szabo, Z., Toth, B., Kovacs, M., Kardos, G., Maraz, A., Rozgonyi, F., Majoros, L. (2008). Evaluation of the New Micronaut-Candida System Compared to the API ID32C Method for Yeast Identification. J. Clin. Microbiol. 46: 1824-1825 [Abstract] [Full Text]  
  • McAlester, G., O'Gara, F., Morrissey, J. P. (2008). Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans. J Med Microbiol 57: 563-569 [Abstract] [Full Text]  
  • Cuellar-Cruz, M., Briones-Martin-del-Campo, M., Canas-Villamar, I., Montalvo-Arredondo, J., Riego-Ruiz, L., Castano, I., De Las Penas, A. (2008). High Resistance to Oxidative Stress in the Fungal Pathogen Candida glabrata Is Mediated by a Single Catalase, Cta1p, and Is Controlled by the Transcription Factors Yap1p, Skn7p, Msn2p, and Msn4p. Eukaryot Cell 7: 814-825 [Abstract] [Full Text]  
  • Cowen, L. E., Steinbach, W. J. (2008). Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance. Eukaryot Cell 7: 747-764 [Full Text]  
  • Goyard, S., Knechtle, P., Chauvel, M., Mallet, A., Prevost, M.-C., Proux, C., Coppee, J.-Y., Schwartz, P., Dromer, F., Park, H., Filler, S. G., Janbon, G., d'Enfert, C. (2008). The Yak1 Kinase Is Involved in the Initiation and Maintenance of Hyphal Growth in Candida albicans. Mol. Biol. Cell 19: 2251-2266 [Abstract] [Full Text]  
  • Li, F., Palecek, S. P. (2008). Distinct domains of the Candida albicans adhesin Eap1p mediate cell-cell and cell-substrate interactions. Microbiology 154: 1193-1203 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ng, K. P., Colombo, A., Finquelievich, J., Barnes, R., Wadula, J., the Global Antifungal Surveillance Group, (2008). Geographic and Temporal Trends in Isolation and Antifungal Susceptibility of Candida parapsilosis: a Global Assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J. Clin. Microbiol. 46: 842-849 [Abstract] [Full Text]  
  • Persat, F., Ranque, S., Derouin, F., Michel-Nguyen, A., Picot, S., Sulahian, A. (2008). Contribution of the (1->3)-{beta}-D-Glucan Assay for Diagnosis of Invasive Fungal Infections. J. Clin. Microbiol. 46: 1009-1013 [Abstract] [Full Text]  
  • Spreghini, E., Maida, C. M., Milici, M. E., Scalise, G., Barchiesi, F. (2008). Posaconazole Activity against Candida glabrata after Exposure to Caspofungin or Amphotericin B. Antimicrob. Agents Chemother. 52: 513-517 [Abstract] [Full Text]  
  • Andes, D., Diekema, D. J., Pfaller, M. A., Prince, R. A., Marchillo, K., Ashbeck, J., Hou, J. (2008). In Vivo Pharmacodynamic Characterization of Anidulafungin in a Neutropenic Murine Candidiasis Model. Antimicrob. Agents Chemother. 52: 539-550 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Nagy, E., Dobiasova, S., Rinaldi, M., Barton, R., Veselov, A., the Global Antifungal Surveillance Group, (2008). Candida krusei, a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J. Clin. Microbiol. 46: 515-521 [Abstract] [Full Text]  
  • Pfaller, M. A., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J., Diekema, D. J. (2008). Selection of a Surrogate Agent (Fluconazole or Voriconazole) for Initial Susceptibility Testing of Posaconazole against Candida spp.: Results from a Global Antifungal Surveillance Program. J. Clin. Microbiol. 46: 551-559 [Abstract] [Full Text]  
  • Rossignol, T., Lechat, P., Cuomo, C., Zeng, Q., Moszer, I., d'Enfert, C. (2008). CandidaDB: a multi-genome database for Candida species and related Saccharomycotina. Nucleic Acids Res 36: D557-D561 [Abstract] [Full Text]  
  • Saville, S. P., Lazzell, A. L., Chaturvedi, A. K., Monteagudo, C., Lopez-Ribot, J. L. (2008). Use of a Genetically Engineered Strain To Evaluate the Pathogenic Potential of Yeast Cell and Filamentous Forms during Candida albicans Systemic Infection in Immunodeficient Mice. Infect. Immun. 76: 97-102 [Abstract] [Full Text]  
  • Shepard, J. R., Addison, R. M., Alexander, B. D., Della-Latta, P., Gherna, M., Haase, G., Hall, G., Johnson, J. K., Merz, W. G., Peltroche-Llacsahuanga, H., Stender, H., Venezia, R. A., Wilson, D., Procop, G. W., Wu, F., Fiandaca, M. J. (2008). Multicenter Evaluation of the Candida albicans/Candida glabrata Peptide Nucleic Acid Fluorescent In Situ Hybridization Method for Simultaneous Dual-Color Identification of C. albicans and C. glabrata Directly from Blood Culture Bottles. J. Clin. Microbiol. 46: 50-55 [Abstract] [Full Text]  
  • Lockhart, S. R., Messer, S. A., Pfaller, M. A., Diekema, D. J. (2008). Lodderomyces elongisporus Masquerading as Candida parapsilosis as a Cause of Bloodstream Infections. J. Clin. Microbiol. 46: 374-376 [Abstract] [Full Text]  
  • Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S., Diekema, D. J. (2008). In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance. J. Clin. Microbiol. 46: 150-156 [Abstract] [Full Text]  
  • Pasquale, T., Tomada, J. R., Ghannoun, M., Dipersio, J., Bonilla, H. (2008). Emergence of Candida tropicalis resistant to caspofungin. J Antimicrob Chemother 61: 219-219 [Full Text]  
  • Johnson, E. M. (2008). Issues in antifungal susceptibility testing. J Antimicrob Chemother 61: i13-i18 [Abstract] [Full Text]  
  • Martins, M., Henriques, M., Azeredo, J., Rocha, S. M., Coimbra, M. A., Oliveira, R. (2007). Morphogenesis Control in Candida albicans and Candida dubliniensis through Signaling Molecules Produced by Planktonic and Biofilm Cells. Eukaryot Cell 6: 2429-2436 [Abstract] [Full Text]  
  • Rachini, A., Pietrella, D., Lupo, P., Torosantucci, A., Chiani, P., Bromuro, C., Proietti, C., Bistoni, F., Cassone, A., Vecchiarelli, A. (2007). An Anti-{beta}-Glucan Monoclonal Antibody Inhibits Growth and Capsule Formation of Cryptococcus neoformans In Vitro and Exerts Therapeutic, Anticryptococcal Activity In Vivo. Infect. Immun. 75: 5085-5094 [Abstract] [Full Text]  
  • Gulshan, K., Moye-Rowley, W. S. (2007). Multidrug Resistance in Fungi. Eukaryot Cell 6: 1933-1942 [Full Text]  
  • Norice, C. T., Smith, F. J. Jr., Solis, N., Filler, S. G., Mitchell, A. P. (2007). Requirement for Candida albicans Sun41 in Biofilm Formation and Virulence. Eukaryot Cell 6: 2046-2055 [Abstract] [Full Text]  
  • Armstrong-James, D. (2007). Invasive Candida species infection: the importance of adequate empirical antifungal therapy. J Antimicrob Chemother 60: 459-460 [Abstract] [Full Text]  
  • Zepelin, M. B.-v., Kunz, L., Ruchel, R., Reichard, U., Weig, M., Gross, U. (2007). Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005. J Antimicrob Chemother 60: 424-428 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Meis, J. F., Gould, I. M., Fu, W., Colombo, A. L., Rodriguez-Noriega, E., and the Global Antifungal Surveillance Group, (2007). Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of Candida Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing. J. Clin. Microbiol. 45: 1735-1745 [Abstract] [Full Text]  
  • Tumbarello, M., Posteraro, B., Trecarichi, E. M., Fiori, B., Rossi, M., Porta, R., de Gaetano Donati, K., La Sorda, M., Spanu, T., Fadda, G., Cauda, R., Sanguinetti, M. (2007). Biofilm Production by Candida Species and Inadequate Antifungal Therapy as Predictors of Mortality for Patients with Candidemia. J. Clin. Microbiol. 45: 1843-1850 [Abstract] [Full Text]  
  • Wiederhold, N. P., Najvar, L. K., Bocanegra, R., Molina, D., Olivo, M., Graybill, J. R. (2007). In Vivo Efficacy of Anidulafungin and Caspofungin against Candida glabrata and Association with In Vitro Potency in the Presence of Sera. Antimicrob. Agents Chemother. 51: 1616-1620 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»